Search for: "Eli Lilly "
Results 381 - 400
of 2,147
Sort by Relevance
|
Sort by Date
16 Jan 2018, 2:15 am
” The Court of Appeal noted that sub-paragraph (ix) above had to be read in the light of the Supreme Court’s judgment in Actavis v Eli Lilly, i.e. that there is in fact a doctrine of equivalents. [read post]
9 Jan 2018, 5:02 pm
And Alex Azar — the former president of Eli Lilly's U.S. operations, now poised to become the top U.S. health official — professes to oppose such tactics.See How Trump’s HHS nominee’s drug company ‘gamed’ a patent Pediatric extensions, which allow for testing of known drugs on young patients, are commonplace. [read post]
7 Jan 2018, 12:47 pm
While the Federal Patent Court denied infringement of Eli Lilly’s patent by Actavis’ generic version comprised of pemetrexed diacid because of the limitation introduced by the patentee during examination proceedings, the Supreme Court disagreed and granted Eli Lilly’s appeal against the decision of the Federal Patent Court. [read post]
27 Dec 2017, 9:44 am
Last Thursday Eli Lilly & Co., the maker of the testosterone product Axiron, announced to Judge Matthew Kennelly in Illinois that an agreement had been reached to settle claims by people injured by Axiron testosterone. [read post]
19 Dec 2017, 2:40 pm
Cir. 2017).(...)We recently applied Akamai V’s “two-prong test” inEli Lilly, a Hatch-Waxman suit brought by Eli Lillyagainst several defendants seeking to launch a genericversion of Eli Lilly’s chemotherapy drug. 845 F.3d at1362. [read post]
19 Dec 2017, 8:35 am
Although the partnership-like relationship between Travel Sentry and TSA differs in several respects from the service provider-customer and physician-patient relationships in Akamai V and Eli Lilly, a common thread connects all three cases: evidence that a third party hoping to obtain access to certain benefits can only do so if it performs certain steps identified by the defendant, and does so under the terms prescribed by the defendant. [read post]
19 Dec 2017, 6:09 am
Eli Lilly & Co. expanded it to the context of multi-district (MDL) litigation. [read post]
9 Dec 2017, 9:14 pm
Jane Love of Gibson, Dunn & Crutcher LLP, Duane Marks of Eli Lilly & Company, and Irena Royzman of Patterson Belknap Webb & Tyler LLP will discuss: • What is now needed by way of written description to create a valid patent on an antibody? [read post]
7 Dec 2017, 9:34 pm
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
Court Of Appeals For Federal Circuit Denies Eli Lilly’s Appeal, Opens Door for Testosterone Generics
5 Dec 2017, 12:29 pm
The Plaintiffs, Eli Lilly and Company, Eli Lilly Export S.A., and Acrux DDS Pty Ltd. had filed a patent infringement lawsuit in the Southern District of Indiana alleging that Defendants, Perrigo Company, Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and 8,807,861,… [read post]
1 Dec 2017, 11:35 am
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
1 Dec 2017, 6:20 am
The Swiss Federal Patent court had originally denied the infringement of Eli Lilly's patent but the Supreme Court granted Eli Lilly, a remarkable event in itself. [read post]
30 Nov 2017, 11:11 am
X ZR 29/15, GRUR 2016/921 (Eli Lilly v Actavis), paras. 83-85). [read post]
28 Nov 2017, 1:05 pm
Therein, we found this excerpt concerning lower limb amputations: These results, from a post-hoc analysis of the landmark EMPA-REG OUTCOME® trial, were shared as an oral presentation on behalf of Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) at the American Heart Association® (AHA) Scientific Sessions 2017 in Anaheim, Calif. and simultaneously published online [as a Research Letter: "Cardiovascular Outcomes and Safety of Empagliflozin in Patients With… [read post]
24 Nov 2017, 7:07 am
Brian CorderyFew would dispute that the Actavis v Eli Lilly decision from the Supreme Court in July 2017 represented – for better or for worse – a major change to the scope of protection of patents in the UK. [read post]
23 Nov 2017, 12:13 am
He gave the example of Eli Lilly which tried to develop a cure against Alzheimer’s disease, invested over a US$ billion and spent ten years in R&D to no avail. [read post]
21 Nov 2017, 1:25 pm
Eli Lilly and Teva have been involved in numerous patent infringement lawsuits against each other in the past. [read post]
18 Nov 2017, 9:00 pm
He is a past director of global corporate affairs for Elanco, a subsidiary of Eli Lilly and Company. [read post]
16 Nov 2017, 9:30 pm
Bush Administration and has worked for the drug company Eli Lilly. [read post]
9 Nov 2017, 9:04 am
Eric Sutton is a senior patent counsel at Oracle and an adjunct professor at Chicago-Kent College of Law. [read post]
